Generic Approvals Continue to Speed Forward

Drug Industry Daily
The FDA approved the most generic drugs during May and June that is has since it began tallying approvals, according to the agency’s latest report on the generics program — helping Commissioner Scott Gottlieb make good on his early-tenure promises to speed generics to market in an effort to lower U.S. drug prices.

To View This Article:


Subscribe To Drug Industry Daily